Elucidating the specific pharmacological mechanism of action (MOA) of Obviously occurring compounds can be tough. Though Tarselli et al. (60) formulated the primary de novo synthetic pathway to conolidine and showcased this In a natural way happening compound effectively suppresses responses to equally chemically induced and inflammation-derived su